US5746775A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of making calcification-resistant bioprosthetic tissue
Assignee: University of Michigan (System)
•
Filing: 1993-10-21
•
Granted: 1998-05-05
•
Expires: 2013-10-21
Abstract
Abstract A method of treating a collagenous biomaterial, such as porcine aortic valve leaflets or bovine pericardium, by exposing the biomaterial to an alcohol to inhibit in vivo calcification. The biomaterial, preferably glutaraldehyde-pretreated, is subjected to an aqueous solution of 60% to 80% lower aliphatic alcohol, such as ethanol for a period of at least 20 minutes, and preferably, 24 to 72 hours. The biomaterial is rinsed, and then stored in either a glutaraldehyde-free environment or an ethanolic solution of glutaraldehyde. In some embodiments, the treatment solutions include an additional anticalcification agent which may be a soluble salt of a metallic cation, such as Al+3 or Fe+3.
Inventors
- 👤 Robert J. Levy
- 👤 Danielle Hirsch
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 18:29
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3683; A61L27/3687; A61L27/3604; A61L27/3625; A61L27/50; A61L27/54; A61L2300/00; A61L2300/10; A61L2300/102; A61L2300/20; A61L2300/21; A61L2300/216; A61L2300/40; A61L2300/45; A61L2400/00; A61L2400/02; A61L2430/00; A61L2430/40; Y; Y10; Y10S; Y10S623/00; Y10S623/92; Y10S623/922
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
107 words
A method of treating a biomaterial, the method comprising the steps of: (1) forming a liquid treatment solution consisting essentially of greater than 50% by volume of a water-soluble C1-C3 aliphatic alcohol in an aqueous buffer of a pH between 6.0 and 8.0; (2) exposing the biomaterial, wherein the biomaterial is a collagenous material derived from a mammalian species selected from the group consisting of bovine pericardium, porcine aortic heart valves, saphenous bypass grafts, aortic homografts, and dura mater, to the liquid treatment solution for a period of time sufficient to render the biomaterial resistant to calcification; and (3) rinsing the exposed biomaterial with a rinsing solution.
Claim 2
Independent Claim
107 words
A method of treating a biomaterial, the method comprising the steps of: (1) forming a liquid treatment solution consisting essentially of greater than 50% by volume of a water-soluble C1-C3 aliphatic alcohol in an aqueous buffer of a pH between 6.0 and 8.0; (2) exposing the biomaterial, wherein the biomaterial is a collagenous material derived from a mammalian species selected from the group consisting of bovine pericardium, porcine aortic heart valves, saphenous bypass grafts, aortic homografts, and dura mater, to the liquid treatment solution for a period of time sufficient to render the biomaterial resistant to calcification; and (3) rinsing the exposed biomaterial with a rinsing solution.
Claim 3
Dependent Claim
20 words
The method of claim 1 wherein the biomaterial rendered resistant to calcification is rendered resistant to in vivo pathologic calcification.
Claim 4
Dependent Claim
19 words
The method of claim 1 wherein said step of exposing comprises immersing the biomaterial in the liquid treatment solution.
Claim 5
Dependent Claim
26 words
The method of claim 3 wherein the alcohol is present in an amount of approximately between 60% and 80% by volume of the liquid treatment solution.
Claim 6
Dependent Claim
14 words
The method of claim 3 wherein the treatment solution further contains an anticalcification agent.
Claim 7
Dependent Claim
35 words
The method of claim 5 wherein the anticalcification agent is a multivalent metallic cation selected from the group consisting of a salt of Al +3 and Fe +3 which is soluble in the treatment solution.
Claim 8
Dependent Claim
22 words
The method of claim 6 wherein the anticalcification agent is AlCl 3 in a concentration range of from about 0.1M to 0.001M.
Claim 9
Dependent Claim
22 words
The method of claim 1 wherein the water-soluble aliphatic alcohol is selected from the group consisting of methanol, ethanol, propanol, and isopropanol.
Claim 10
Dependent Claim
12 words
The method of claim 8 wherein the water-soluble aliphatic alcohol is ethanol.
Claim 11
Dependent Claim
11 words
The method of claim 1 wherein the biomaterial has been cross-linked.
Claim 12
Dependent Claim
13 words
The method of claim 10 wherein the biomaterial has been crosslinked with glutaraldehyde.
Claim 13
Dependent Claim
22 words
The method of claim 1 wherein the time sufficient to render the biomaterial resistant to calcification is at least about 20 minutes.
Claim 14
Dependent Claim
23 words
The method of claim 12 wherein the time sufficient to render the biomaterial resistant to calcification is between about 24 to 96 hours.
Claim 15
Dependent Claim
22 words
The method of claim 1 wherein there is provided the further step of storing the treated biomaterial in a sterile, glutaraldehyde-free environment.
Claim 16
Dependent Claim
28 words
The method of claim 1 wherein there is provided the further step of storing the treated biomaterial in a storage solution of a lower aliphatic alcohol and glutaraldehyde.
Claim 17
Dependent Claim
30 words
The method of claim 15 wherein the storage solution is an aqueous solution containing approximately between 60% to 80% by volume of ethanol and approximately between 0.2% to 0.5% glutaraldehyde.
Claim 18
Dependent Claim
18 words
The method of claim 3 wherein the biomaterial is an aortic valve cusp and the alcohol is ethanol.
Claim 19
Dependent Claim
23 words
The method of claim 5 wherein the biomaterial is an aortic valve wall, and the anticalcification agent is an aluminum salt in ethanol.
Claim 20
Dependent Claim
17 words
The method of claim 1 wherein there is provided the further step of sterilizing the bioprosthetic tissue.
Claim 21
Dependent Claim
22 words
The method of claim 3 wherein the treatment solution is buffered to a pH in the range of between 7.0 and 7.6.
Claim 22
Dependent Claim
17 words
The method of claim 20 wherein the liquid treatment solution is buffered to a pH of 7.4.
Claim 23
Dependent Claim
23 words
The method of claim 4 wherein the alcohol is present in an amount of approximately 80% by volume of the liquid treatment solution.
Claim 24
Independent Claim
97 words
A method of making calcification-resistant biomaterial for use in the interior of a human or animal, the method comprising the steps of: a) subjecting glutaraldehyde pre-treated bioprosthetic tissue, wherein the bioprosthetic tissue is a collagenous material derived from a mammalian species selected from the group consisting of bovine pericardium, porcine aortic heart valves, saphenous bypass grafts, aortic homografts, and dura mater, to an aqueous, treatment solution of at least about 50% by volume of a water-soluble C1-C3 aliphatic alcohol for a period of time between about 20 minutes and 96 hours; and b) rinsing the bioprosthetic tissue.
Claim 25
Independent Claim
97 words
A method of making calcification-resistant biomaterial for use in the interior of a human or animal, the method comprising the steps of: a) subjecting glutaraldehyde pre-treated bioprosthetic tissue, wherein the bioprosthetic tissue is a collagenous material derived from a mammalian species selected from the group consisting of bovine pericardium, porcine aortic heart valves, saphenous bypass grafts, aortic homografts, and dura mater, to an aqueous, treatment solution of at least about 50% by volume of a water-soluble C1-C3 aliphatic alcohol for a period of time between about 20 minutes and 96 hours; and b) rinsing the bioprosthetic tissue.
Claim 26
Dependent Claim
35 words
The method of claim 23 wherein there is provided the further step of: c) storing the bioprosthetic tissue in a sterile, buffered solution of approximately between 0.2% to 0.5% glutaraldehyde and at least 60% ethanol.
Claim 27
Dependent Claim
10 words
The method of claim 23 wherein the alcohol is ethanol.
Claim 28
Dependent Claim
34 words
The method of claim 23 wherein the solution further contains an anticalcification agent which is a multivalent metallic cation selected from the group consisting of a salt of A1 +3 and Fe +3 .
Claim 29
Dependent Claim
15 words
The method of claim 26 wherein the anticalcification agent is an aluminum salt in ethanol.
Claim 30
Dependent Claim
25 words
The method of claim 23 wherein the alcohol is present in an amount of approximately between 60% and 80% by volume of the treatment solution.
Claim 31
Dependent Claim
23 words
The method of claim 28 wherein the alcohol is present in an amount of approximately 80% by volume of the liquid treatment solution.
Claim 32
Independent Claim
133 words
A method of treating a biomaterial, the method comprising the steps of: (1) forming a liquid treatment solution consisting essentially of a water-soluble C1-C3 aliphatic alcohol in an amount of greater than about 40% by volume and a further organic solvent, wherein the combined amount of the alcohol and organic solvent is greater than about 50% by volume, in an aqueous buffer at pH between about 6.0 and 8.0; (2) exposing the biomaterial, wherein the biomaterial is a collagenous material derived from a mammalian species selected from the group consisting of bovine pericardium, porcine aortic heart valves, saphenous bypass grafts, aortic homografts, and dura mater, to the liquid treatment solution for a period of time sufficient to render the biomaterial resistant to calcification; and (3) rinsing the exposed biomaterial in a rinsing solution.
Claim 33
Independent Claim
133 words
A method of treating a biomaterial, the method comprising the steps of: (1) forming a liquid treatment solution consisting essentially of a water-soluble C1-C3 aliphatic alcohol in an amount of greater than about 40% by volume and a further organic solvent, wherein the combined amount of the alcohol and organic solvent is greater than about 50% by volume, in an aqueous buffer at pH between about 6.0 and 8.0; (2) exposing the biomaterial, wherein the biomaterial is a collagenous material derived from a mammalian species selected from the group consisting of bovine pericardium, porcine aortic heart valves, saphenous bypass grafts, aortic homografts, and dura mater, to the liquid treatment solution for a period of time sufficient to render the biomaterial resistant to calcification; and (3) rinsing the exposed biomaterial in a rinsing solution.
Claim 34
Dependent Claim
17 words
The method of claim 30 wherein the treatment solution includes about 40% alcohol and 40% organic solvent.
Claim 35
Dependent Claim
13 words
A biomaterial produced by the process of claims 1 or 23 or 30.
References Cited (Backward Citations)
US725648A
Cited
US713046A
Cited
US2750251A
Cited
US2970031A
Cited
US3560141A
Cited
US3974526A
Cited
US3922356A
Cited
US4097234A
Cited
US4378224A
Cited
US4323358A
Cited
US4648881A
Cited
US4647283A
Cited
WO1983003335A1
Cited
US4481009A
Cited
US4405327A
Cited
US4402697A
Cited
WO1984001894A1
Cited
WO1984001879A1
Cited
US5215541A
Cited
US4885005A
Cited
US4597960A
Cited
US4753652A
Cited
US4553974A
Cited
US4770665A
Cited
US4729139A
Cited
US4786287A
Cited
EP0267434A2
Cited
US4798611A
Cited
US4838888A
Cited
US5080670A
Cited
US4976733A
Cited
US5002566A
Cited
US5476516A
Cited
US5447536A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-05-04 | 2001-11-03 | 2002-05-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-05-04 | 2005-11-03 | 2006-05-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-05-04 | 2009-11-03 | 2010-05-05 | $7700.00 | Window Closed / Lapsed |